Here's What Key Metrics Tell Us About Health Catalyst (HCAT) Q3 Earnings

Zacks
Zacks kaynağında aç
Here's What Key Metrics Tell Us About Health Catalyst (HCAT) Q3 Earnings

For the quarter ended September 2026, Health Catalyst (HCAT) reported revenue of $56.28 million, down 26.3% over the same period last year. EPS came in at -$0.03, compared to $0.06 in the year-ago quarter.

The reported revenue represents a surprise of +1.98% over the Zacks Consensus Estimate of $55.19 million. With the consensus EPS estimate being -$0.02, the EPS surprise was -50%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Health Catalyst performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Professional services: $15.6 million compared to the $12.14 million average estimate based on two analysts. The reported number represents a change of -35.7% year over year. Revenue- Technology: $40.69 million versus $43.07 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -21.8% change. Adjusted Gross Profit- Professional Services: $0.27 million versus the two-analyst average estimate of $0.67 million. Adjusted Gross Profit- Technology: $24.65 million compared to the $24.66 million average estimate based on two analysts.

View all Key Company Metrics for Health Catalyst here>>>

Shares of Health Catalyst have returned -9.7% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Beyond Nvidia: AI's Second Wave Is Here

The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.

See Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Health Catalyst, Inc. (HCAT): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research